NCT01828398.

Trial name or title	tDCS and robotic therapy in stroke
Methods	RCT with parallel‐group design
Participants	Estimated enrolment: 40 Inclusion criteria: age > 18 years; first‐ever ischaemic stroke; impairment of the upper limb; TCT score > 50 Exclusion criteria: insufficient understanding in Italian to complete any test; MMSE‐score < 24; contraindications to single‐pulse TMS; history of epilepsy; frequent headaches or neck pain; implanted devices; contraindications to tDCS; neurological or psychiatric pathology; severe cardio‐pulmonary, renal, hepatic diseases; pregnancy
Interventions	2 arms Dual‐tDCS with the anode placed over M1 of the affected hemisphere and the cathode placed over M1 of the unaffected hemisphere (1 mA for 30 min) plus robotic therapy (5 times a week for 30 minutes for 2 weeks) Sham tDCS (not explicitly described) plus robotic therapy (5 times a week for 30 minutes for 2 weeks)
Outcomes	Outcomes will be recorded at baseline (further time points not stated) Primary outcome measure: UE‐FM Secondary outcome measures BBT MAS MAL Cortical excitability
Starting date	November 2011
Contact information	Sofia Straudi, MD University Hospital of Ferrara Ferrara, Italy
Notes